
Dr. Mazzocchi discusses the limits and benefits of immunotherapies, as well as the importance of genetic testing in determining cancer diagnosis and treatment in patients.

Dr. Mazzocchi discusses the limits and benefits of immunotherapies, as well as the importance of genetic testing in determining cancer diagnosis and treatment in patients.

Exenatide extended-release represents the first regulatory approval for a once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) for pediatric patients with type 2 diabetes.

Males and patients with higher disease severity were more likely to attend program sessions.

New guidelines on aortic valve implantation in risk groups with aortic stenosis shifted from risk strata to a focus on patient age and life expectancy.

More research is needed to understand the pathogenesis underlying this association.

The treatment was associated with an increased risk of C difficile colitis.

While investigators did not meet their primary endpoint in the study, results in former smokers within the trial were promising and prompted further research on the subgroup.

The FDA will also not meet the PDUFA date for tofacitinib for the treatment of active ankylosing spondylitis.

CBGT and MBSR were both associated with a significant decrease in negative emotion.

Data show a significant association between wearable tracker use and increased physical activity during a 15-week period.

Gastrointestinal infections were the most common serious infections associated with biologics, according to a cohort analysis.

Andrea Mazzocchi, PhD, explains how tissue and blood samples can be used to improve detection, progression, and treatment for cancer in patients.

Data show while women with GDM wanted to be responsible for their own health, an annual reminder and combined appointments would help to screen for T2D.

On this episode of Coping After COVID, Dr. Craig Chepke discusses the challenges for schizophrenia patients.

Orphaned children experience greater risk of abuse and health complications, prompting a call to action for greater research and management of COVID-19 in ailing countries.

The rare liver disease can often lead to liver failure.

A study notes that irradiation did not impact transfusion requirements or relevant laboratory values among patients receiving chronic blood transfusions.

A leading author of a recent Oxford study speaks of azithromycin, its limitations in treating patients with COVID-19, and the importance of properly utilizing the antibiotic.

Data show no significant difference in survival rates in the canukinumab group (88.8%) compared to placebo (85.7%).

Data show postoperative initiation of factor XI inhibition was effective method for reducing the risk of VTE following total knee arthroplasty.

The issuance comes within a week of the planned PDUFA date for the drug's possible indication as an adult CKD therapy.

The researchers found sero-protection rate at 12-month was significantly higher in the ID arm compared to the IM cohort.

More randomized controlled trials are needed to assess their long-term effectiveness, safety, and effects on health-related quality of life.

Using a participant group culled from several countries, investigators believe they have a better understanding on what contributes to uncontrolled allergic rhinitis and what it means for future patient care.

The co-founder and CEO of Known Medicine dissects the art and science of how profiling biomarkers, epigenetics and the microenvironment may provide the synergy needed to revolutionize the oncologic landscape.

Data show total amount of patients pre-guideline was 558,175 compared to 532,962 patients after the release of the guideline.

Second opinions are mutually beneficial for patients and doctors alike, and the availability of a second opinion has become exponentially easier in recent years due to changes in virtual medicine.

In a single-center study, no patients were screened annually for HIV and HCV.

Researchers aimed to establish new treatments for patients with COVID-19, but found no evidence of antiviral benefits or decreases in hospitalization and ventilation rates.